ARCB – arcbest corporation (US:NASDAQ)
Stock Stats
News
Clinical Trial Supplies Market Analysis Report 2025-2029: Breakdown by Manufacturing, Sourcing, Packaging, Labelling, Logistics, Small Molecules, Biologics, Vaccines [Yahoo! Finance]
Will Weakness in ArcBest Corporation's (NASDAQ:ARCB) Stock Prove Temporary Given Strong Fundamentals? [Yahoo! Finance]
ArcBest Co. (NASDAQ: ARCB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $108.00 to $97.00. They now have a "neutral" rating on the stock.
ArcBest Co. (NASDAQ: ARCB) had its price target lowered by analysts at Jefferies Financial Group Inc. from $120.00 to $95.00. They now have a "buy" rating on the stock.
ArcBest Co. (NASDAQ: ARCB) had its price target lowered by analysts at Citigroup Inc. from $83.00 to $66.00. They now have a "neutral" rating on the stock.
Form SCHEDULE 13G/A ARCBEST CORP /DE/ Filed by: DIMENSIONAL FUND ADVISORS LP
Form ARS ARCBEST CORP /DE/ For: Dec 31
Form DEFA14A ARCBEST CORP /DE/
Form DEF 14A ARCBEST CORP /DE/ For: Apr 25
Form 4 ARCBEST CORP /DE/ For: Mar 13 Filed by: Beasley John Matthew
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.